世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Global Women’s Health Technology Market Size study & Forecast, by Technology type (Surgical, Diagnostic, Contraceptive, Labor & Delivery, Critical Care), By Indication (Cancer, Infertility, Menstruation, Pregnancy, Post-menopausal Syndrome, Pelvic Disorders, Infectious Diseases), By End Users (Hospitals, Obstetrics & Gynaecology Clinics, Diagnostics Laboratory, Ambulatory Surgery Centers (ASC)), and Regional Analysis, 2022-2029


Global Women’s Health Technology Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX over the forecast period 2022-2029.... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Bizwit Research & Consulting LLP
ビズウィットリサーチ&コンサルティング
2023年3月6日 US$4,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
200 英語

 

サマリー

Global Women’s Health Technology Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX over the forecast period 2022-2029. Women's health technology refers to the use of medical devices, software, and digital tools that are specifically designed to address women's unique health needs. It encompasses a wide range of technologies that can help women manage their health, including tools for reproductive health, menstrual cycle tracking, breast health, menopause, pregnancy, and more. These technologies are designed to provide women with personalized and effective healthcare solutions that cater to their specific needs and empower them to take control of their health and well-being. The market demand is primarily driven by the factors such as increased awareness and demand for personalized healthcare, greater emphasis on preventative healthcare by providing tools for early detection and prevention of health issues which prevent the onset of chronic diseases.

In addition, with increasing female presence in healthcare as providers, researchers, and innovators, there is a growing emphasis on addressing women's specific health needs. This has led to increased investment and development of women's health technology. According to World Health Organization (WHO), Women make approximately 67% of the worldwide health and social care workforce. It is estimated that women provide significant health services to around 5 billion people worldwide. Women's contributions to health-care systems are estimated to be worth more than USD 3 trillion every year. Furthermore, the increasing investments towards the research & development of women’s health, as well as the development of new diagnostic and treatment technologies are presenting lucrative opportunities for market growth over the forthcoming years. However, regulatory processes could be time-consuming and expensive which can limit the investment for new products, that is restricting the market growth over the forecast period of 2022-2029.

The key regions considered for the Global Women’s Health Technology Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the substantial investments made by the major businesses in the invention of creative solutions and technologies for women's health. Also, the prevalence of disorders including post-menopausal syndromes, breast cancer, pelvic or ureteral cancer, and others are rising. Whereas, Asia Pacific is also expected to grow at the highest growth rate over the forecasting period. Factors such as the increase in birth rates, more knowledge of women's health technology, and other health concerns are burgeoning the market growth in the forecasting years.

Major market players included in this report are:
Chiaro Technology Ltd
NaturalCycles Nordic AB
Ava Science Inc.
UE LifeSciences Inc.
Aspect Imaging Ltd.
Celmatix Inc.
Assurex Health Inc.
Rho Capital Partners
Evofem Biosciences Inc.
Embr Labs

Recent Developments in the Market:
 In October 2022, Iraq and Afghanistan Veterans of America (IAVA), the main voice of the post-9/11 generation of veterans, is delighted to announce its new relationship with Assurex Health, which is now Myriad Neuroscience Genetics, Inc., a leading genetic testing and precision medicine firm. The GeneSight® test is available to assist doctors to understand how a patient's genes may influence how they metabolise and/or respond to certain drugs routinely used for depression, anxiety, ADHD, and other mental illnesses.
 In November 2021, Ava, the first FDA-cleared fertility tracking wearable, announced that it will now be available as a workplace family-building benefit support tool through a partnership with WINFertility (WIN), the nation's leading fertility benefits management company with the largest employer client portfolio. The collaboration will enable WIN to make the Ava bracelet available to its members, providing an alternative route to data-driven technology that boosts the possibilities of natural conception.

Global Women’s Health Technology Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology type, Indication, End Users, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology type:
Surgical
Diagnostic
Contraceptive
Labor & Delivery
Critical Care



By Indication:
Cancer
Infertility
Menstruation
Pregnancy
Post-menopausal Syndrome
Pelvic Disorders
Infectious Diseases

By End Users:
Hospitals
Obstetrics & Gynaecology Clinics
Diagnostics Laboratory
Ambulatory Surgery Centers (ASC)

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World










ページTOPに戻る


目次

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Women’s Health Technology Market, by Region, 2019-2029 (USD Billion)
1.2.2. Women’s Health Technology Market, by Technology type, 2019-2029 (USD Billion)
1.2.3. Women’s Health Technology Market, by Indication, 2019-2029 (USD Billion)
1.2.4. Women’s Health Technology Market, by End Users, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Women’s Health Technology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Women’s Health Technology Market Dynamics
3.1. Women’s Health Technology Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increased awareness and demand for personalized healthcare.
3.1.1.2. Emphasis on preventative healthcare.
3.1.1.3. Growing female representation in healthcare as providers, researchers, and innovators.
3.1.2. Market Challenges
3.1.2.1. Regulatory processes could be time-consuming and expensive.
3.1.3. Market Opportunities
3.1.3.1. Increasing investments towards research & development.
3.1.3.2. Development of new diagnostic and treatment technologies.
Chapter 4. Global Women’s Health Technology Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Women’s Health Technology Market, by Technology type
6.1. Market Snapshot
6.2. Global Women’s Health Technology Market by Technology type, Performance - Potential Analysis
6.3. Global Women’s Health Technology Market Estimates & Forecasts by Technology type 2019-2029 (USD Billion)
6.4. Women’s Health Technology Market, Sub Segment Analysis
6.4.1. Surgical
6.4.2. Diagnostic
6.4.3. Contraceptive
6.4.4. Labor & Delivery
6.4.5. Critical Care
Chapter 7. Global Women’s Health Technology Market, by Indication
7.1. Market Snapshot
7.2. Global Women’s Health Technology Market by Indication, Performance - Potential Analysis
7.3. Global Women’s Health Technology Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
7.4. Women’s Health Technology Market, Sub Segment Analysis
7.4.1. Cancer
7.4.2. Infertility
7.4.3. Menstruation
7.4.4. Pregnancy
7.4.5. Post-Menopausal Syndrome
7.4.6. Pelvic Disorders
7.4.7. Infectious Diseases
Chapter 8. Global Women’s Health Technology Market, by End Users
8.1. Market Snapshot
8.2. Global Women’s Health Technology Market by End Users, Performance - Potential Analysis
8.3. Global Women’s Health Technology Market Estimates & Forecasts by End Users 2019-2029 (USD Billion)
8.4. Women’s Health Technology Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Obstetrics and Gynaecology Clinics
8.4.3. Diagnostic Laboratory
8.4.4. Ambulatory Surgery Centers (ASC)
Chapter 9. Global Women’s Health Technology Market, Regional Analysis
9.1. Women’s Health Technology Market, Regional Market Snapshot
9.2. North America Women’s Health Technology Market
9.2.1. U.S. Women’s Health Technology Market
9.2.1.1. Technology type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. End Users breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Women’s Health Technology Market
9.3. Europe Women’s Health Technology Market Snapshot
9.3.1. U.K. Women’s Health Technology Market
9.3.2. Germany Women’s Health Technology Market
9.3.3. France Women’s Health Technology Market
9.3.4. Spain Women’s Health Technology Market
9.3.5. Italy Women’s Health Technology Market
9.3.6. Rest of Europe Women’s Health Technology Market
9.4. Asia-Pacific Women’s Health Technology Market Snapshot
9.4.1. China Women’s Health Technology Market
9.4.2. India Women’s Health Technology Market
9.4.3. Japan Women’s Health Technology Market
9.4.4. Australia Women’s Health Technology Market
9.4.5. South Korea Women’s Health Technology Market
9.4.6. Rest of Asia Pacific Women’s Health Technology Market
9.5. Latin America Women’s Health Technology Market Snapshot
9.5.1. Brazil Women’s Health Technology Market
9.5.2. Mexico Women’s Health Technology Market
9.5.3. Rest of Latin America Women’s Health Technology Market
9.6. Rest of The World Women’s Health Technology Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Chiaro Technology Ltd
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. NaturalCycles Nordic AB
10.2.3. Ava Science Inc.
10.2.4. UE LifeSciences Inc.
10.2.5. Aspect Imaging Ltd.
10.2.6. Celmatix Inc.
10.2.7. Assurex Health Inc.
10.2.8. Rho Capital Partners
10.2.9. Evofem Biosciences Inc.
10.2.10. Embr Labs
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

Bizwit Research & Consulting LLP社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD(surgical)の最新刊レポート


よくあるご質問


Bizwit Research & Consulting LLP社はどのような調査会社ですか?


Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る